Pinealon 10mg Nasal Spray

Description

This pinealon nasal spray supplies Pinealon, a synthetic tripeptide with the sequence Glu-Asp-Arg, abbreviated EDR. It is one of the short peptide bioregulators from the St Petersburg Institute of Bioregulation and Gerontology, and it is studied mainly in neuronal models for effects on oxidative stress and cell survival. One point of confusion is worth clearing immediately: Pinealon and Epitalon are different peptides, EDR and AEDG respectively, both associated with pineal research but not interchangeable. Supplied for laboratory research use only.

The permeability question comes first

Every claim made for this compound depends on it getting inside a cell, and for a neuronal target, getting into the brain. Both deserve scrutiny rather than assumption.

The Pinealon peptide is a synthetic tripeptide whose third residue is arginine, and EDR carries two acidic residues alongside that one basic residue, which makes it a small, highly charged molecule. Charged molecules do not diffuse across lipid membranes readily. The proposed mechanism for this whole class requires the peptide to reach the nucleus, which means crossing a plasma membrane and then a nuclear envelope. That is a substantial ask for a charged tripeptide, and demonstrating it in your own system is a more useful experiment than assuming it from the literature.

There are plausible routes. Peptide transporters exist, and small peptides can enter cells through carrier-mediated transport rather than passive diffusion, which is exactly how KPV enters intestinal epithelium via PepT1. Whether an equivalent route operates for EDR in neurons is a question rather than a settled fact, and it is the question I would want answered before building a programme on this compound.

For anyone considering intranasal pinealon research, the nose-to-brain literature is worth reading with the same caution. That route is far better established for small lipophilic molecules than for charged peptides, and rodent nasal anatomy differs from human enough that cross-species comparison needs care. Nothing about the supplied format here constitutes guidance for administration to anything.

Where the claims come from, and how they are packaged

Pinealon is sold almost entirely on cognitive and sleep language, so the vocabulary is worth separating from the chemistry.

Its pineal association is the origin of the sleep framing: the pineal gland governs melatonin production and the circadian rhythm, and a compound named after that tissue inherits the association whether or not the pharmacology supports it. The cognitive framing runs alongside, with cognitive function, cognitive enhancement, brain fog and general nootropic positioning doing most of the selling. Serotonin turns up in that copy as a proposed mediator, which is plausible for anything touching central nervous system signalling and unproven for this molecule specifically. Claims of superior bioavailability from a spray format describe packaging rather than pharmacology.

The compound is rarely sold alone. It appears in combination products with Epithalon, with DSIP in sleep-oriented blends, and in neuro stacks pairing it with Semax and Selank. Those are separate active ingredients with separate evidence, and a blend result cannot be attributed to any one of them. Compounds such as gonadorelin turn up in the same catalogues without sharing any mechanism. Therapeutic peptides is the category label used across all of it, and peptide therapy is a clinical term that does not apply to research material.

The disease contexts named in this space are Alzheimer’s disease and Huntington’s disease, both of which appear because neuronal apoptosis and neuroprotection are the endpoints the Khavinson group reported in animal models. Neither is an established outcome for this peptide and neither is claimed here.

Designing an oxidative stress experiment properly

The neuroprotection claim for this peptide is usually framed around oxidative stress, so the experiment has to be built around a defined stressor rather than unstressed cells.

A protective compound has nothing to protect against in a healthy culture, so the design needs an insult: hydrogen peroxide, glutamate excitotoxicity, oxygen-glucose deprivation, or a mitochondrial toxin such as rotenone, applied at a concentration that produces measurable but submaximal damage. If the insult kills everything, no protection is detectable; if it kills nothing, there is no window. Titrating the stressor before testing the compound is the step people skip.

Readouts divide into viability, oxidative markers and mechanism. Viability by a metabolic assay plus a membrane-integrity assay, since each alone can mislead. Oxidative markers including reactive oxygen species probes, lipid peroxidation as malondialdehyde or 4-HNE, and the glutathione to oxidised glutathione ratio, which shifts by an order of magnitude between healthy and stressed cells and is the most informative single redox measure available. Mechanism by apoptosis markers such as caspase-3 activation, and transcript changes by qPCR given the proposed transcriptional mechanism.

Two controls decide whether the result means anything. A positive control antioxidant, N-acetylcysteine or Trolox, establishes that your assay can detect protection at all. And a free amino acid control at matched concentration addresses the possibility that a rapidly hydrolysed tripeptide is delivering glutamate, aspartate and arginine rather than acting as an intact molecule. Arginine in particular is a nitric oxide precursor with its own effects in neuronal systems, which makes that control more than a formality here.

Pinealon nasal spray specifications

What the evidence supports, and what it does not

The mechanistic proposal shared across this series is that short peptides enter cells, reach the nucleus and interact with DNA promoter regions or chromatin-associated histones, changing which genes are accessible. Supporting work includes mobility shift assays showing peptide-DNA complexes, histone binding assays and docking models, argued in Short Peptides Regulate Gene Expression in the Bulletin of Experimental Biology and Medicine.

For Pinealon specifically the evidence is essentially all cell culture and animal work originating from a small set of related laboratories. There are no human clinical trials and no regulatory approval anywhere. High-resolution structural confirmation of a peptide-DNA complex has not been published for any member of the series. That is a thinner evidence base than most compounds in this catalogue, and it is why this page is shorter than the ones for peptides with deeper literatures. A short honest description is worth more than a long inflated one.

Pinealon nasal spray storage and handling

EDR contains no cysteine, no methionine and no tryptophan, so oxidation, disulfide chemistry and light sensitivity are not the practical concerns here. Charge and enzymatic exposure are.

With two acidic residues and an arginine, this peptide’s charge state and solubility are strongly pH-dependent, so buffer control is more consequential than it looks. A tripeptide is also a ready substrate for serum peptidases, meaning long incubations in serum-containing medium give a declining and poorly defined exposure. Sensible pinealon nasal spray storage is otherwise routine: cold, sealed, out of light, single-use aliquots rather than repeated freeze-thaw, and low-binding plasticware at low working concentrations. Lyophilized peptides require reconstitution before use, generally with bacteriostatic water, and the diluent belongs in your methods. Comparisons against subcutaneous injection describe routes into an organism rather than anything measurable in a well. This research peptide is a neuropeptide by class and is supplied for laboratory work only.

How research grade pinealon spray is characterized

Short, highly charged peptides retain poorly on standard reversed-phase columns, so for EDR the analytical method behind a purity figure matters more than the figure itself. Hydrophilic interaction chromatography, ion-pairing or ion exchange paired with mass spectrometry is what suits a molecule like this, and a certificate stating an appropriate method is worth more than a bare percentage from an unstated one. A research grade pinealon spray is supplied under the same verification PrymaLab applies across its research peptides, HPLC and MS confirmation plus independent third-party testing. No specific lot figures are asserted here; request the certificate of analysis for the lot you receive.

For related bioregulator research, see the PrymaLab Research Library.

Frequently asked questions

What is Pinealon?

Pinealon is a synthetic tripeptide, Glu-Asp-Arg (EDR), one of the Khavinson-class short peptide bioregulators, studied in neuronal models for oxidative stress and cell survival. Material supplied here is a research chemical for in-vitro laboratory use only.

Is Pinealon the same as Epitalon?

No. Pinealon is EDR, a tripeptide. Epitalon is AEDG, a tetrapeptide. Both are associated with pineal research within the same programme, but they are different molecules with different studied endpoints and they are not interchangeable.

Can Pinealon enter cells?

That deserves testing rather than assuming. EDR is small and highly charged, and charged molecules do not cross lipid membranes readily. The proposed mechanism requires nuclear entry, so demonstrating uptake in your own system is more useful than inferring it from the literature.

What controls does an oxidative stress experiment need?

A titrated stressor producing submaximal damage, a positive control antioxidant such as N-acetylcysteine or Trolox to show the assay can detect protection, and a free amino acid control, since hydrolysis would deliver glutamate, aspartate and arginine, and arginine has its own activity in neuronal systems.

Is Pinealon nasal spray approved for human use?

No. This material is a research chemical for in-vitro laboratory use only, has no FDA or EMA approval, and is not intended for human or veterinary use. Nothing here is medical advice.

Ordering and compliance

Every PrymaLab research compound ships from the United States and is sold research-use-only. This pinealon peptide nasal spray is supplied for in-vitro laboratory research, is not intended for human or veterinary use, is not a drug or supplement, and has not been evaluated by the FDA for the research-chemical context. Verify the legal status of any research compound in your jurisdiction before ordering. Certificates of analysis are available on request for the lot you receive.